FDA Inspection
Sant P. Chawla, MDSant P. Chawla, MD – FDA Inspection, Aug 27, 2009
Record Details
This FDA Inspection record concerns Sant P. Chawla, MD, with an inspection on August 27, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sant P. Chawla, MD
- Inspection Date
- August 27, 2009
- Product Type
- Drugs
View Company Profile
ID · 6e65d272-0251-4f01-8690-84c1abbbd856
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 604145
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sant P. Chawla, MD
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2026 | Not classified | Los Angeles District Office | Bioresearch Monitoring |
| April 15, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 13, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 13, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 30, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sant P. Chawla, MD
- FDA Inspection 1324454 - 2026-06-30
- FDA Inspection 1167324 - 2022-04-15
- FDA Inspection 945678 - 2015-10-13
- FDA Inspection 757044 - 2011-12-13
- FDA Inspection 757043 - 2011-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.